This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Hemoglobin Monitor Market

Market Insights on Hemoglobin Monitor covering sales outlook, demand forecast & up-to-date key trends

Hemoglobin Monitor Market by Product Type, Output Capacity & Region - Forecast 2022 - 2032

Hemoglobin Monitor Market Outlook

The hemoglobin monitor market is expected to record a CAGR of 7.8% during the forecast period 2022-2032, up from US$ 1 Billion in the year 2020 to reach a valuation of US$1.7 Billion by 2032.

The hemoglobin monitor market is anticipated to show promising growth prospects in the forecasted period 2022-2032.

With recent technological advances, smartphone applications equipped with algorithms to detect hemoglobin levels are changing future trends in hemoglobin monitoring. Furthermore, this shift towards non-invasive hemoglobin monitors is expected to affect the parent sector's business models and investment strategies.

Advances in technology and the modes and operations of hemoglobin monitors are changing the behavior of customers and end-users when purchasing these devices, and consequently increasing the hemoglobin monitor's market share.

Report Attributes

Details

CAGR

7.8%

Value (2022)

US$1 Billion

Value (2032)

US$1.7 Billion

During the forecast period, there will be significant growth in the hemoglobin monitor market globally. The growth in blood donation creates more lucrative business opportunities for the hemoglobin monitor market, and companies currently operating on the market.

Hemoglobin monitors are a multifaceted market comprised of prominent innovators, regional distributors, and small players looking for survival. Each hemoglobin monitor uses a different type of mechanism and is used to deliver better clinical results.

With emerging trends in the hemoglobin monitor market, it is hoped that non-invasive hemoglobin monitors will ultimately replace traditional hemoglobin monitors, enabling hemoglobin monitor manufacturers to produce an optimal number of units. The continuous monitoring of blood will lead to an increase in demand for hemoglobin monitor manufacturing.

As important as the developed economies are to the industry, emerging economies are also moving at a good pace with regard to the adoption of the hemoglobin monitor market. Founded on the basis of quality infrastructure and an installed base that support hemoglobin monitor production, North America is estimated to have a significant market share in the hemoglobin monitor market.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Drivers to the Hemoglobin Monitor Market Share?

The cost associated with manufacturing a hemoglobin monitor is determined by its size, purpose, and features. Having recently been approved by the US FDA, hemoglobin monitors of compact size will likely drive sales of the hemoglobin monitor market.

With the availability of small hemoglobin monitors, the cost will be reduced, and subsequently, the demand for hemoglobin monitors will increase. It is anticipated that the change in the nature of the product, namely the point-of-care version, will increase the demand for hemoglobin monitors in long-term care.

Technological advancements such as wireless connectivity are anticipated to increase the demand and acceptability of hemoglobin monitors as well as increase the up-gradation of hemoglobin monitors. Patients suffering chronically from diabetes are expected to raise the requirement for these devices.

The limitations to the growth of the hemoglobin monitor market can be downward pricing pressure from respective regulatory bodies to expand the reach of hemoglobin monitors at affordable prices.

Which Region holds the Highest Growth Potential in the Hemoglobin Monitor Market?

Geographically, the hemoglobin monitor market is segmented into seven regions, viz. South Asia, East Asia, Europe, Latin America, North America, Oceania, and the Middle East and Africa.

Blood donation is an important part of the hemoglobin monitoring market. By donating more blood units, more such products could be manufactured, thereby propelling hemoglobin monitor market opportunities. While developed economies will continue to play an important role in the hemoglobin monitor market, emerging economies are also taking the market by storm.

In the hemoglobin monitor market, North America is expected to have a significant share, in part because of its quality infrastructure and installed base, which supports the demand for hemoglobin monitors. It is followed by Europe, East Asia, and Oceania.

Given the current change in adoption and growth in the general pharmaceutical market, the South Asia hemoglobin monitor market could prove lucrative for manufacturers and industry professionals. Other reasons for the lucrative market growth for hemoglobin monitors in South Asia are its large population and its disease burden.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is the Competitive Landscape in the Hemoglobin Monitor Market?

The present market structure of the hemoglobin monitor market is expected to change with efforts and research present in the clinical phase.

The involved in the market of hemoglobin monitor market include Masimo Corporation, Bayer AG, Siemens Healthineers, Welch Allyn, Inc., Koninklijke Philips N.V, Medtronic plc, Nihon Kohden Corporation, GE Healthcare, Smiths Group, and Omron Healthcare.

Scope Of Report

Report Attribute

Details

Growth rate

CAGR of 7.8% from 2022 to 2032

Base year for estimation

2021

Historical data

2017 – 2021

Forecast period

2022 – 2032

Quantitative units

Revenue in US$ billion, and CAGR from 2022 to 2032.

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis

Segments covered

Product type, modality, end-user, and geography

Regional scope

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  •  Oceania
  • Middle East and Africa

Country scope

  • U.S.
  • North America
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Asia Pacific
  • Japan
  • China
  • India
  • Latin America
  • Mexico
  • Brazil
  • Middle-East and Africa
  • South Africa
  • Saudi Arabia

Key companies profiled

  • Masimo Corporation
  • Bayer AG
  • Siemens Healthineers
  • Welch Allyn, Inc.
  • Koninklijke Philips N.V
  • Medtronic plc
  • Nihon Kohden Corporation
  • GE Healthcare
  • Smith’s Group and Omron Healthcare.

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Key Segments Profiled in the Hemoglobin Monitor Market

By Product Type:

  • Connectivity
  • Wired
  • Non-wired
  • Convenience
  • Invasive
  • Non-invasive

By Modality:

  • Handheld
  • Bench Top
  • Modular

By End User:

  • Hospital
  • Ambulatory Surgical Centre’s
  • Specialty Clinic
  • Home care setting
  • Healthcare Facilities
  • Emergency Medical Services

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

In the forecast period 2022-2032, the hemoglobin monitor market is expected to rise from US$1 Billion in the year 2020 to US$1.7 Billion by 2032 with a CAGR of 7.8%, which indicates promising growth prospects.

Key players holding substantial hemoglobin monitor market share include Masimo Corporation, Bayer AG, Siemens Healthineers, Welch Allyn, Inc., Koninklijke Philips N.V, Medtronic plc, Nihon Kohden Corporation, GE Healthcare, Smiths Group, and Omron Healthcare.

As per the analysis, the hemoglobin monitor market share is likely to be US$1.7 Billion by 2032.

Because of the approval of the U.S. FDA, hemoglobin monitor sales are likely to increase. Small hemoglobin monitors will lower the cost, increasing their demand. In addition, growth of the hemoglobin monitors market will be driven by technological advances such as wireless connectivity.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Antibacterial Haemostatic Gels Market

Published : August 2021

Healthcare

Hemoglobin Monitor Market

Published : September 2019

Healthcare

Glycohemoglobin Analyzers Market

Published : October 2018

Healthcare

Blood Clot Retrieval Devices Market

Published : December 2016

Google translate

Hemoglobin Monitor Market